U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07005154) titled 'A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer' on May 27.
Brief Summary: Hormone therapy, or androgen deprivation therapy (ADT) is a standard way to treat prostate cancer. It works by reducing the amount of the main male sex hormone, testosterone in the body. Androgen receptor pathway inhibitors (ARPIs) are another type of hormone therapy. They either slow down how much testosterone is made or block testosterone from reaching the prostate cancer cells. Abiraterone acetate (AA) is an ARPI that is used to treat advanced prostate cancer. This type of treatment is usually given as a tablet with a...